Nyxoah SA Share Holder Equity 2021-2026 | NYXH

Nyxoah SA share holder equity from 2021 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nyxoah SA Annual Share Holder Equity
(Millions of US $)
2025 $56
2024 $123
2023 $106
2022 $127
2021 $176
2020 $111
Nyxoah SA Quarterly Share Holder Equity
(Millions of US $)
2026-06-30 $97
2026-03-31 $42
2025-12-31 $56
2025-09-30 $56
2025-06-30 $83
2025-03-31 $98
2024-12-31 $123
2024-09-30 $115
2024-06-30 $129
2024-03-31 $95
2023-12-31 $106
2023-09-30 $118
2023-06-30 $126
2023-03-31 $134
2022-12-31 $127
2022-09-30 $134
2022-06-30 $147
2022-03-31 $160
2021-06-30 $103
2021-03-31 $110
2020-12-31 $111
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.060B $0.011B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.168B 43.07
Tempus AI (TEM) United States $12.423B 0.00
10x Genomics (TXG) United States $9.692B 0.00
Hinge Health (HNGE) United States $7.455B 71.62
Hims & Hers Health (HIMS) United States $6.498B 0.00
Doximity (DOCS) United States $4.601B 28.36
Heartflow (HTFL) United States $4.202B 0.00
IRhythm Holdings (IRTC) United States $3.688B 243.22
Privia Health (PRVA) United States $2.601B 96.95
Clover Health Investments (CLOV) United States $2.475B 0.00
Inspire Medical Systems (INSP) United States $2.157B 32.86
Butterfly Network (BFLY) United States $2.077B 0.00
Schrodinger (SDGR) United States $1.716B 0.00
Omnicell (OMCL) United States $1.484B 21.19
Azenta (AZTA) United States $1.447B 78.64
Enovis (ENOV) United States $1.035B 5.36
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.668B 0.00
Phreesia (PHR) United States $0.642B 34.50
Claritev (CTEV) United States $0.602B 0.00
Veradigm (MDRX) United States $0.594B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Evolent Health (EVH) United States $0.423B 0.00
Carlsmed (CARL) United States $0.416B 0.00
Senseonics Holdings (SENS) United States $0.371B 0.00
CapsoVision (CV) United States $0.319B 0.00
Standard BioTools (LAB) United States $0.271B 0.00
American Well (AMWL) United States $0.226B 0.00
KORU Medical Systems (KRMD) United States $0.145B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.132B 0.00
Health Catalyst (HCAT) United States $0.129B 0.00
CareCloud (CCLD) United States $0.087B 6.41
Pulmonx (LUNG) United States $0.082B 0.00
Zepp Health (ZEPP) Netherlands $0.064B 0.00
Outset Medical (OM) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.058B 0.00
EUDA Health Holdings (EUDA) Singapore $0.051B 0.00
Precipio (PRPO) United States $0.049B 0.00
MDxHealth SA (MDXH) Belgium $0.033B 0.00
111 (YI) China $0.031B 0.00
Evaxion - (EVAX) Denmark $0.025B 0.00
HeartBeam (BEAT) United States $0.024B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
HeartSciences (HSCS) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
DataMeds AI (MEDS) United States $0.005B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00